TABLE 1.
Proportion of patients who received genomically matched therapies in the first and second periods
| Core hospital | 1st period | 2nd period | P value | ||
|---|---|---|---|---|---|
| No. of patients who underwent CGP testing | No. of patients who received “matched” therapies (%) | No. of patients who underwent CGP testing (%) | No. of patients who received “matched” therapies | ||
| A | 75 | 3 (4.0%) | 138 | 18 (13.0%) | |
| B | 73 | 2 (2.7%) | 201 | 12 (6.0%) | |
| C | 5 | 0 (0.0%) | 102 | 3 (2.9%) | |
| D | 41 | 0 (0.0%) | 158 | 6 (3.8%) | |
| E | 160 | 16 (10.0%) | 251 | 23 (9.2%) | |
| F | 172 | 4 (2.3%) | 450 | 47 (10.4%) | |
| G | 13 | 1 (7.7%) | 83 | 9 (10.8%) | |
| H | 85 | 0 (0.0%) | 218 | 15 (6.9%) | |
| I | 13 | 0 (0.0%) | 142 | 16 (11.3%) | |
| J | 24 | 0 (0.0%) | 221 | 6 (2.7%) | |
| K | 93 | 2 (2.2%) | 179 | 9 (5.0%) | |
| L | ‐ | ‐ | 151 | 12 (7.9%) | |
| Total | 754 | 28 (3.7%) | 2294 | 176 (7.7%) | <0.001 |
Abbreviation: CGP, comprehensive genomic profiling.